15/04/2026
Herpes zoster vaccination shows significant cardio-protective benefits in patients with atherosclerotic cardiovascular disease. Vaccinated individuals demonstrate reduced incidence of major adverse cardiovascular events, including myocardial infarction and stroke.
Proposed mechanisms involve decreased inflammation and thrombotic risk following prevention of viral reactivation. Findings reinforce current recommendations and highlight potential expanded benefits beyond infection prevention.